11/21
04:34 am
tnxp
Muscarinic Acetylcholine Receptor M1 Antagonists Pipeline Research Report 2024: Comprehensive Insights on 8+ Drugs Featuring Tonix Pharmaceuticals, BMS, WinSanTor, and Apnimed [Yahoo! Finance]
High
Report
Muscarinic Acetylcholine Receptor M1 Antagonists Pipeline Research Report 2024: Comprehensive Insights on 8+ Drugs Featuring Tonix Pharmaceuticals, BMS, WinSanTor, and Apnimed [Yahoo! Finance]
11/21
03:09 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/18
04:05 pm
tnxp
Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
High
Report
Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
11/18
07:12 am
tnxp
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting [Yahoo! Finance]
Low
Report
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting [Yahoo! Finance]
11/18
07:00 am
tnxp
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
Neutral
Report
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
11/14
07:57 am
tnxp
Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments [Yahoo! Finance]
Low
Report
Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments [Yahoo! Finance]
11/14
07:30 am
tnxp
Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments
Low
Report
Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments
11/13
04:22 pm
tnxp
Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting [Yahoo! Finance]
Low
Report
Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting [Yahoo! Finance]
11/13
04:05 pm
tnxp
Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
Low
Report
Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
11/13
09:08 am
tnxp
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company's Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals [Yahoo! Finance]
Medium
Report
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company's Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals [Yahoo! Finance]
11/13
09:05 am
tnxp
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
Medium
Report
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
11/13
03:02 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/12
08:00 am
tnxp
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
Low
Report
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights
11/5
02:15 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/4
07:00 am
tnxp
Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
Medium
Report
Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
11/1
07:00 am
tnxp
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
Medium
Report
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
10/29
08:00 am
tnxp
Tonix Pharmaceuticals to Present at BIO-Europe® 2024
Medium
Report
Tonix Pharmaceuticals to Present at BIO-Europe® 2024
10/28
02:03 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/25
08:00 am
tnxp
Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
Low
Report
Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
10/24
08:00 am
tnxp
Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024
Medium
Report
Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024
10/20
02:08 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/17
08:00 am
tnxp
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
High
Report
Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
10/16
08:58 am
tnxp
Tonix Pharmaceuticals announces submission of NDA for non-opioid analgesic [Seeking Alpha]
Medium
Report
Tonix Pharmaceuticals announces submission of NDA for non-opioid analgesic [Seeking Alpha]
10/16
08:00 am
tnxp
Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)
High
Report
Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)
10/12
02:05 am
tnxp
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.